Asahi Kasei Medical Co., Ltd. Sustainability Profile
Asahi Kasei Medical Co., Ltd., a prominent subsidiary of Asahi Kasei Corporation, is headquartered in Japan and operates extensively across Asia, Europe, and North America. Founded in 1948, the company has established itself as a leader in the medical device and healthcare industry, focusing on innovative solutions in dialysis, blood management, and regenerative medicine. With a commitment to enhancing patient care, Asahi Kasei Medical offers a range of unique products, including advanced dialysis equipment and biocompatible materials. Their dedication to research and development has led to significant milestones, positioning them as a trusted name in the medical field. Recognised for their quality and reliability, Asahi Kasei Medical continues to make strides in improving healthcare outcomes globally.
DitchCarbon Score
How does Asahi Kasei Medical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Asahi Kasei Medical Co., Ltd.'s score of 72 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Asahi Kasei Medical Co., Ltd., headquartered in Japan (JP), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Asahi Kasei Corporation, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Asahi Kasei Medical Co., Ltd., it is important to note that emissions data and performance metrics may be cascaded from its parent company, Asahi Kasei Corporation. This cascading occurs at a level 2 relationship, meaning that the parent company’s initiatives and performance may inform the subsidiary's climate strategies. Asahi Kasei Corporation has been active in addressing climate change, and any relevant targets or achievements in emissions reduction would likely be applicable to Asahi Kasei Medical Co., Ltd. as part of the corporate family. However, specific details regarding these initiatives or targets are not provided in the available data. In summary, while Asahi Kasei Medical Co., Ltd. does not currently disclose its own emissions data or reduction targets, it is positioned within a corporate structure that may influence its climate commitments through the practices of its parent company.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2000 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 | - | - | - | - | - | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Asahi Kasei Medical Co., Ltd.'s Industry?
How Carbon Intensive is Asahi Kasei Medical Co., Ltd.'s Location?
Asahi Kasei Medical Co., Ltd.'s Scope 3 Categories Breakdown
Asahi Kasei Medical Co., Ltd.'s Scope 3 emissions, which decreased by 0% last year and increased by approximately 113% since 2015, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 79% of total emissions under the GHG Protocol, with "End-of-Life Treatment of Sold Products" being the largest emissions source at 41% of Scope 3 emissions.
Top Scope 3 Categories
Asahi Kasei Medical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Asahi Kasei Medical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.